BIGMAR INC
10QSB, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: BIGMAR INC, 10QSB, 2000-08-14
Next: ZEROPLUS COM INC, 8-K, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         297,520
<SECURITIES>                                         0
<RECEIVABLES>                                1,944,262
<ALLOWANCES>                                         0
<INVENTORY>                                  2,551,475
<CURRENT-ASSETS>                             5,127,677
<PP&E>                                      18,551,581
<DEPRECIATION>                               5,128,827
<TOTAL-ASSETS>                              18,892,599
<CURRENT-LIABILITIES>                        7,584,738
<BONDS>                                     10,020,783
                                0
                                          0
<COMMON>                                         9,794
<OTHER-SE>                                   1,277,284
<TOTAL-LIABILITY-AND-EQUITY>                18,892,599
<SALES>                                      3,895,460
<TOTAL-REVENUES>                             3,895,460
<CGS>                                        3,168,282
<TOTAL-COSTS>                                3,168,282
<OTHER-EXPENSES>                             2,892,314
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             442,309
<INCOME-PRETAX>                            (2,607,445)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,607,445)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                361,837
<CHANGES>                                            0
<NET-INCOME>                               (2,245,608)
<EPS-BASIC>                                     (0.24)
<EPS-DILUTED>                                   (0.24)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission